# TERF2

## Overview
TERF2, or telomeric repeat binding factor 2, is a gene in humans that encodes the protein telomeric repeat binding factor 2. This protein is a crucial component of the shelterin complex, which is essential for the protection and maintenance of telomeres, the protective caps at the ends of chromosomes. The TERF2 protein binds to double-stranded telomeric DNA and plays a significant role in preventing chromosome end-to-end fusions and maintaining genomic stability. It is involved in various cellular processes including telomere length regulation, chromosome end protection, and the control of telomere replication. The protein's function is vital for cellular aging, proliferation, and overall organismal health, with implications in aging and cancer (Kumar2017Identifying; van1998TRF2).

## Structure
The molecular structure of the TERF2 protein, encoded by the human TERF2 gene, includes several distinct domains crucial for its function in telomere protection. The TERF2 protein contains a TERF homology (TRFH) domain, which is important for homodimerization, allowing two TERF2 molecules to pair and function effectively. This dimerization is essential for the protein's role in the shelterin complex and telomere maintenance (Bhari2021Shelterin). Additionally, TERF2 features a Myb domain, which specifically binds to the double-stranded telomeric DNA, playing a critical role in recognizing and protecting telomere ends (Kuimov2004Polypeptide; Bhari2021Shelterin).

Despite the importance of these domains, detailed information on the primary, secondary, tertiary, and quaternary structures of TERF2 is not provided in the available literature excerpts. Similarly, while the presence of post-translational modifications and splice variant isoforms is hinted at, specific details such as the nature of these modifications or the differences between isoforms are not elaborated upon (Kuimov2004Polypeptide).

In summary, while the functional domains of TERF2 are well-characterized, further studies are required to elucidate the complete structural details at the molecular level.

## Function
TERF2, also known as telomeric repeat binding factor 2, is a critical component of the shelterin complex that plays a pivotal role in the maintenance and protection of telomeres, the specialized structures at the ends of chromosomes. The protein encoded by TERF2 binds to the double-stranded DNA of telomeres through its c-myb DNA-binding domains, which is essential for preserving the integrity of these chromosome ends (Kumar2017Identifying). TERF2 is specifically involved in maintaining the correct DNA configuration of the telomeric 3' overhang, preventing undesirable end-to-end fusions of chromosomes (van1998TRF2). This function is crucial in protecting telomeres when they reach a critically shortened state, which otherwise could lead to genomic instability and various diseases (Kumar2017Identifying).

In addition to its structural role, TERF2 negatively regulates telomere length by promoting the formation of t-loops and inhibiting the activation of the ATM pathway at telomeres (Kumar2017Identifying). This regulation helps maintain telomere length within a range that preserves cell viability and function, influencing cellular aging and proliferation (Smogorzewska2000Control). The dynamic regulation of telomere length by TERF2, along with TRF1, involves a protein-counting model where the transition between 'open' and 'closed' states of telomeres is governed by the amount of these proteins bound to the telomere, affecting telomerase access and telomere elongation (Smogorzewska2000Control). 

Overall, the activities of TERF2 are vital for maintaining the stability and integrity of the genome, which has significant implications for organismal health and longevity.

## Clinical Significance
TERF2, or telomeric repeat binding factor 2, has been implicated in the progression and severity of multiple myeloma (MM), a type of blood cancer. Studies have shown that TERF2, as part of the shelterin complex, plays a crucial role in telomere maintenance, which is essential for cellular survival and impacts disease progression. Elevated mRNA and protein levels of TERF2 have been observed in MM patients compared to controls, and these levels are associated with disease severity and poor prognosis (Kumar2017Identifying). Furthermore, TERF2 has demonstrated high sensitivity and specificity as a biomarker for predicting disease occurrence in MM, with significant associations found in univariate analysis with disease progression (Kumar2017Identifying).

In addition to MM, alterations in TERF2 expression have been noted in other cancers. Studies have linked changes in TERF2 expression to disease causation and progression in various types of cancers, including breast cancer and T-cell acute leukemia (Kumar2017Identifying). These findings underscore the potential of TERF2 as a biomarker for not only MM but also other malignancies, highlighting its clinical significance in cancer diagnosis and prognosis.

## Interactions
TERF2, also known as telomeric repeat binding factor 2, is a critical component of the shelterin complex, which plays a pivotal role in the protection and maintenance of telomeres. TERF2 primarily binds to the double-stranded DNA (dsDNA) of telomeres through its c-myb DNA-binding domains, crucial for the formation of t-loops at the telomeres. These t-loops are essential for protecting chromosome ends from unwanted recombination, repair, and degradation (Kumar2017Identifying). 

TERF2 interacts with RAP1, another component of the shelterin complex, helping to stabilize the structure of telomeres and maintain genome stability by protecting telomeres from recombination (Kumar2017Identifying). Additionally, TERF2 is involved in interactions with the TERF2IP protein, which is crucial for the protein's function. Mutations in the TERF2IP gene, such as the p.R364X nonsense mutation, disrupt the TERF2 binding domain, highlighting the importance of this interaction (Aoude2014Nonsense).

Furthermore, TERF2 has been shown to interact with p53, where p53 shows a higher affinity for the single-strand 3' overhang and the loop tail junction of t-loops, potentially increasing the probability of t-loop formation in the presence of TERF2 (Kuimov2004Polypeptide). This interaction suggests a regulatory role of TERF2 in cellular senescence and telomere maintenance, further emphasizing its importance in chromosomal stability and cellular longevity.


## References


[1. (van1998TRF2) Bas van Steensel, Agata Smogorzewska, and Titia de Lange. Trf2 protects human telomeres from end-to-end fusions. Cell, 92(3):401â413, February 1998. URL: http://dx.doi.org/10.1016/s0092-8674(00)80932-0, doi:10.1016/s0092-8674(00)80932-0. (1331 citations) 10.1016/s0092-8674(00)80932-0](https://doi.org/10.1016/s0092-8674(00)80932-0)

[2. (Kuimov2004Polypeptide) A. N. Kuimov. Polypeptide components of telomere nucleoprotein complex. Biochemistry (Moscow), 69(2):117â129, February 2004. URL: http://dx.doi.org/10.1023/b:biry.0000018941.81962.1c, doi:10.1023/b:biry.0000018941.81962.1c. (33 citations) 10.1023/b:biry.0000018941.81962.1c](https://doi.org/10.1023/b:biry.0000018941.81962.1c)

[3. (Kumar2017Identifying) Raman Kumar, Rehan Khan, Nidhi Gupta, Tulika Seth, Atul Sharma, Mani Kalaivani, and Alpana Sharma. Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (terf2), in multiple myeloma. Leukemia &amp; Lymphoma, 59(7):1677â1689, October 2017. URL: http://dx.doi.org/10.1080/10428194.2017.1387915, doi:10.1080/10428194.2017.1387915. (16 citations) 10.1080/10428194.2017.1387915](https://doi.org/10.1080/10428194.2017.1387915)

[4. (Smogorzewska2000Control) Agata Smogorzewska, Bas van Steensel, Alessandro Bianchi, Stefan Oelmann, Matthias R. Schaefer, Gisela Schnapp, and Titia de Lange. Control of human telomere length by trf1 and trf2. Molecular and Cellular Biology, 20(5):1659â1668, March 2000. URL: http://dx.doi.org/10.1128/mcb.20.5.1659-1668.2000, doi:10.1128/mcb.20.5.1659-1668.2000. (573 citations) 10.1128/mcb.20.5.1659-1668.2000](https://doi.org/10.1128/mcb.20.5.1659-1668.2000)

[5. (Bhari2021Shelterin) Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, and Rajeev Mishra. Shelterin complex gene: prognosis and therapeutic vulnerability in cancer. Biochemistry and Biophysics Reports, 26:100937, July 2021. URL: http://dx.doi.org/10.1016/j.bbrep.2021.100937, doi:10.1016/j.bbrep.2021.100937. (15 citations) 10.1016/j.bbrep.2021.100937](https://doi.org/10.1016/j.bbrep.2021.100937)

[6. (Aoude2014Nonsense) Lauren G. Aoude, Antonia L. Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, VÃ­ctor Quesada, Peter Johansson, Jane M. Palmer, Andrew J. Ramsay, Xijun Zhang, Kristine Jones, Judith Symmons, Elizabeth A. Holland, Helen Schmid, Vanessa Bonazzi, Susan Woods, Ken Dutton-Regester, Mitchell S. Stark, Helen Snowden, Remco van Doorn, Grant W. Montgomery, Nicholas G. Martin, Thomas M. Keane, Carlos LÃ³pez-OtÃ­n, Anne-Marie Gerdes, HÃ¥kan Olsson, Christian Ingvar, Ãke Borg, Nelleke A. Gruis, Jeffrey M. Trent, GÃ¶ran JÃ¶nsson, D. Timothy Bishop, Graham J. Mann, Julia A. Newton-Bishop, Kevin M. Brown, David J. Adams, and Nicholas K. Hayward. Nonsense mutations in the shelterin complex genes acd and terf2ip in familial melanoma. JNCI: Journal of the National Cancer Institute, December 2014. URL: http://dx.doi.org/10.1093/jnci/dju408, doi:10.1093/jnci/dju408. (194 citations) 10.1093/jnci/dju408](https://doi.org/10.1093/jnci/dju408)